Abstract
Background
With stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.
Objectives
To assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.
Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.
With stroke burden increasing, there remains a need to identify therapeutic options that ameliorate the acute insult. There is substantial evidence for a neuroprotective effect of marine-derived n-3 polyunsaturated fatty acids (PUFAs), associated with better functional outcomes in experimental stroke models.
Objectives
To assess the effects of administration of marine-derived n-3 PUFAs on functional outcomes and dependence in people with stroke.
Our secondary outcomes were vascular-related death, recurrent events, incidence of other type of stroke, adverse events, quality of life, and mood.
| Original language | English |
|---|---|
| Pages (from-to) | e314-e315 |
| Number of pages | 2 |
| Journal | Stroke |
| Volume | 50 |
| Issue number | 11 |
| Early online date | 26 Sep 2019 |
| DOIs | |
| Publication status | Published - 1 Nov 2019 |
Keywords
- stroke
- treatment
- functional recovery
- marine-derived n-3 PUFAs
- death
- n-3 fatty acids
- quality of life
- incidence
- neuroprotective effect
Access to Document
- Accepted Manuscript
This is the author's accepted manuscript of an article published in Stroke. The final published version can be found at: https://www.ahajournals.org/doi/10.1161/STROKEAHA.119.026919